financetom
Business
financetom
/
Business
/
Precision Drilling Edges Up After Hours as It Gets TSX Nod for a New Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Precision Drilling Edges Up After Hours as It Gets TSX Nod for a New Normal Course Issuer Bid
Sep 11, 2025 1:54 PM

04:43 PM EDT, 09/11/2025 (MT Newswires) -- Precision Drilling ( PDS ) edged up in after-hours New York trading after the company said Thursday afternoon it received approval from the Toronto Stock Exchange to launch a new normal course issuer bid (NCIB) to buy up to nearly 1.3 million common shares, or about 10% of its public float as of Sept. 5.

The buyback may begin on Sept. 19 and will run for 12 months unless completed or terminated earlier, the company said.

To support the new buyback, Precision also plans to enter into an automatic share purchase plan starting Sept. 19. This will allow a broker to buy shares on the company's behalf during blackout periods or other restricted times, following pre-set trading rules in line with Canadian and US regulations, the company added.

Precision shares were last seen up US$0.23 to US$57.11 after hours. They closed down $0.61 to $78.72 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UAW says workers at VW Tennessee plant file for union election
UAW says workers at VW Tennessee plant file for union election
Mar 18, 2024
WASHINGTON, March 18 (Reuters) - The United Auto Workers said Monday that workers at Volkswagen's Chattanooga, Tennessee, assembly plant are seeking an election to unionize, setting up a critical test for UAW President Shawn Fain's unprecedented campaign to expand the union's reach to foreign-owned automakers in the southern United States. The UAW said a supermajority of eligible workers at the...
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Gap Insider Sold Shares Worth $704,603, According to a Recent SEC Filing
Mar 18, 2024
10:13 AM EDT, 03/18/2024 (MT Newswires) -- Sarah Gilligan, Chief Sup Chn & Transform Ofcr, on March 14, 2024, sold 31,167 shares in Gap (GPS) for $704,603. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000003991124000041/xslF345X03/edgardoc.xml Price: 24.57, Change: +0.98, Percent Change: +4.15 ...
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Update: Nuvei Confirms Considering Expressions of Interest, Other Options; RBC Says Timing of Talks 'Made Sense'; Up over 25% in US, Canada Trading
Mar 18, 2024
10:14 AM EDT, 03/18/2024 (MT Newswires) -- Nuvei Corp. ( NVEI ) announced overnight Sunday that it is aware of recent media reports speculating as to a potential going-private transaction involving the company. This comes after Reuters on Saturday cited a source familiar with the matter as saying private equity firm Advent International is in advanced talks to buy Nuvei...
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
Mar 18, 2024
Friday, the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted positively (8-3) favoring expanded use of Bristol Myers Squibb & Co ( BMY )  2seventy bio Inc’s  Abecma (idecabtagene vicleucel). The panel said Abecma demonstrated a favorable benefit/risk profile for patients with triple-class exposed relapsed or refractory multiple myeloma based on the pivotal Phase 3 KarMMa-3 study results, including the key secondary endpoint of overall...
Copyright 2023-2026 - www.financetom.com All Rights Reserved